Drug:
Reaction: SEIZURE
20260101 - 20261231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 26824244 |
US |
70 | |
Renal mass, Gastrointestinal haemorrhage, Colonoscopy, Product dose omission issue, Seizure, Therapy interrupted, |
||||
CENOBAMATE, CENOBAMATE, CLOBAZAM, ESCITALOPRAM, |
||||
| 602 | 26824727 |
AU |
50 | 2 |
Neuralgia, Meibomian gland dysfunction, Diplopia, Seizure, Eye pain, Dry mouth, Eyelid thickening, Facial pain, |
||||
TIRZEPATIDE, |
||||
| 603 | 26824969 |
EU |
58 | 1 |
Iridocyclitis, Hospitalisation, Tuberculosis, Pyrexia, Seizure, Speech disorder, Back pain, Arthralgia, General physical health deterioration, C-reactive protein increased, Pyrexia, Hypersensitivity, Cough, Mycobacterium tuberculosis complex test positive, C-reactive protein increased, Granuloma, Splenomegaly, Drug ineffective, |
||||
INFLIXIMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 604 | 26818213 |
BR |
39 | 2 |
Seizure, Hypersensitivity, Panic attack, Anxiety disorder, Feeding disorder, Weight decreased, Asthenia, Malaise, Product administration interrupted, |
||||
PANITUMUMAB, |
||||
| 605 | 26818297 |
US |
1 | |
Hospitalisation, Seizure, Condition aggravated, Mouth haemorrhage, |
||||
LAMOTRIGINE, |
||||
| 606 | 26818711 |
US |
1 | |
Seizure, Mitochondrial cytopathy, Liver disorder, |
||||
DIVALPROEX SODIUM, |
||||
| 607 | 26818833 |
US |
57 | 1 |
Arthralgia, Seizure, |
||||
PEGLOTICASE, |
||||
| 608 | 26819142 |
US |
2 | |
Seizure, Malaise, COVID-19, |
||||
UBROGEPANT, |
||||
| 609 | 26819292 |
US |
58 | 1 |
Seizure, |
||||
ABATACEPT, |
||||
| 610 | 26842168 |
30 | ||
Seizure, Pain, Disability, |
||||
MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 611 | 26813234 |
EU |
7 | 1 |
Seizure, |
||||
EVOLOCUMAB, |
||||
| 612 | 26813284 |
EU |
50 | 2 |
Seizure, Hypoglycaemia, Fatigue, Myalgia, Tachycardia, Dizziness, Dyspnoea, Chest pain, |
||||
| 613 | 26813389 |
1 | ||
Seizure, Product substitution issue, Therapeutic product effect incomplete, |
||||
BRIVARACETAM, BRIVARACETAM INJECTION, |
||||
| 614 | 26813707 |
IN |
19 | 1 |
Post transplant lymphoproliferative disorder, Gastrointestinal haemorrhage, Seizure, Septic shock, High-grade B-cell lymphoma, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 615 | 26813914 |
GB |
40 | 2 |
Altered state of consciousness, Pneumonitis aspiration, Generalised tonic-clonic seizure, Seizure, Encephalopathy, Hepatic function abnormal, Swollen tongue, Eosinophilia, Thrombocytosis, Agitation, Hepatic steatosis, Paradoxical drug reaction, Toxicity to various agents, Intentional overdose, Off label use, |
||||
FEXOFENADINE, FEXOFENADINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, CLOBAZAM, CLOBAZAM, CLOBAZAM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CENOBAMATE, CENOBAMATE, CENOBAMATE, |
||||
| 616 | 26814191 |
CA |
56 | 1 |
Hypovolaemic shock, Seizure, Altered state of consciousness, Arrhythmia, Hypotension, Ventricular tachycardia, |
||||
IRBESARTAN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AMLODIPINE, CARBOXYMETHYLCELLULOSE SODIUM, NICOTINE, NICOTINE TRANSDERMAL SYSTEM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREGABALIN, ALBUTEROL SULFATE, ALBUTEROL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TIOTROPIUM BROMIDE, |
||||
| 617 | 26814699 |
40 | 2 | |
Paradoxical drug reaction, Altered state of consciousness, Pneumonitis aspiration, Encephalopathy, Hepatic steatosis, Thrombocytosis, Depressed level of consciousness, Generalised tonic-clonic seizure, Hepatic function abnormal, Swollen tongue, Eosinophilia, Agitation, Toxicity to various agents, Hepatotoxicity, Intentional overdose, Seizure, Seizure, Platelet count increased, Blood alkaline phosphatase increased, Gamma-glutamyltransferase increased, Aspartate aminotransferase increased, |
||||
LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, CARBAMAZEPINE, CLOBAZAM, CLOBAZAM, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, CENOBAMATE, CENOBAMATE, CENOBAMATE, CENOBAMATE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 618 | 26814719 |
GB |
2 | |
Loss of consciousness, Seizure, Dizziness, Panic attack, Malaise, |
||||
USTEKINUMAB-TTWE, |
||||
| 619 | 26815090 |
US |
40 | 2 |
Seizure, Balance disorder, Vomiting, Blood cholesterol increased, Vertigo, Product dose omission issue, |
||||
TROFINETIDE, LACOSAMIDE, |
||||
| 620 | 26815310 |
US |
1 | |
Brain operation, Seizure, |
||||
INFLIXIMAB-AXXQ, |
||||
| 621 | 26815392 |
US |
70 | |
Seizure, Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, |
||||
| 622 | 26815414 |
US |
67 | 2 |
Seizure, Dyspnoea exertional, Headache, Nausea, Fatigue, Oedema peripheral, Orthopnoea, Palpitations, Dry eye, Dry mouth, Dyspnoea, Myalgia, Muscular weakness, Arthralgia, Back pain, Swelling, Asthenia, Hypoaesthesia, Depression, Increased tendency to bruise, Constipation, |
||||
EVOLOCUMAB, EVOLOCUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ISOSORBIDE DINITRATE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, ERGOCALCIFEROL, |
||||
| 623 | 26815474 |
US |
||
Seizure, |
||||
APALUTAMIDE, |
||||
| 624 | 26815784 |
US |
1 | |
Seizure, |
||||
LAMOTRIGINE, |
||||
| 625 | 26816136 |
US |
2 | |
Seizure, |
||||
STIRIPENTOL, CLOBAZAM, |
||||
| 626 | 26816149 |
US |
2 | |
Seizure, |
||||
BUPROPION HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, |
||||
| 627 | 26816237 |
7 | 1 | |
Tremor, Seizure, Hypersomnia, Head lag, Body temperature decreased, Human rhinovirus test positive, Enterovirus test positive, Ear infection, Nasopharyngitis, Irritability, Vomiting, |
||||
| 628 | 26816701 |
77 | 1 | |
Abdominal distension, Diarrhoea, Seizure, Unresponsive to stimuli, Amnesia, Balance disorder, Coordination abnormal, Amnesia, |
||||
PANCRELIPASE, LEVETIRACETAM, |
||||
| 629 | 26816809 |
GB |
19 | 1 |
Rash, Swollen tongue, Mouth ulceration, Lymphadenopathy, Furuncle, Suicidal ideation, Seizure, White blood cell count increased, Swelling face, Acne, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, CARBAMAZEPINE, CARBAMAZEPINE, |
||||
| 630 | 26816845 |
EU |
58 | 2 |
Seizure, Product administration issue, |
||||
SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE, |
||||
| 631 | 26816858 |
1 | ||
Seizure, |
||||
PERAMPANEL, |
||||
| 632 | 26821752 |
26 | 2 | |
Seizure, |
||||
OXCARBAZEPINE, OXCARBAZEPINE, |
||||
| 633 | 26808987 |
KR |
60 | 1 |
Varicella zoster virus infection, Drug ineffective, Optic neuritis, Depressed level of consciousness, Cerebral infarction, Seizure, Arterial stenosis, Vasculitis, |
||||
DOXORUBICIN, DOXORUBICIN, RITUXIMAB, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, POLATUZUMAB VEDOTIN, IFOSFAMIDE, IFOSFAMIDE FOR INJECTION, CISPLATIN, BENDAMUSTINE HCL, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, ACYCLOVIR, ACYCLOVIR, CARBOPLATIN, PREDNISONE, ETOPOSIDE, ETOPOSIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 634 | 26809532 |
US |
2 | |
Seizure, |
||||
TROFINETIDE, TROFINETIDE, |
||||
| 635 | 26809601 |
US |
||
Seizure, |
||||
TROFINETIDE, |
||||
| 636 | 26809629 |
31 | ||
Seizure, Electrocardiogram QT prolonged, Unresponsive to stimuli, Generalised tonic-clonic seizure, Muscle rigidity, Myoclonus, Mental status changes, Confusional state, Muscle contractions involuntary, Condition aggravated, Sedation, Overdose, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 637 | 26810054 |
GB |
71 | 2 |
Cerebrovascular accident, Blood pressure increased, Seizure, Headache, Chest pain, |
||||
INFLIXIMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, TENECTEPLASE, AMLODIPINE, LABETALOL, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LORAZEPAM, TRANEXAMIC ACID, MESALAMINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 638 | 26810393 |
US |
28 | 1 |
Cardiogenic shock, Intentional overdose, Toxicity to various agents, Lethargy, Obstructive airways disorder, Seizure, Pulseless electrical activity, Toxic cardiomyopathy, Hypoxia, Pulmonary toxicity, Pulmonary oedema, Pneumonia, Chronic respiratory failure, |
||||
BUPROPION HYDROCHLORIDE, CLONAZEPAM, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 639 | 26810594 |
CA |
26 | 2 |
Seizure, Movement disorder, Muscle rigidity, Mouth haemorrhage, Oral discharge, Somnolence, Abdominal discomfort, Stomatitis, Toothache, Tongue biting, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 640 | 26810697 |
US |
38 | 2 |
Hospitalisation, Seizure, |
||||
TROFINETIDE, LEVETIRACETAM, LACOSAMIDE, CENOBAMATE, PHENOBARBITAL, CLONAZEPAM, |
||||
| 641 | 26811161 |
|||
Haematochezia, Seizure, Respiratory tract congestion, Mucous stools, Constipation, |
||||
VIGABATRIN, VIGABATRIN, VIGABATRIN, |
||||
| 642 | 26811184 |
EU |
50 | 1 |
Seizure, Therapy change, |
||||
SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 643 | 26811480 |
13 | 2 | |
Seizure, |
||||
MIGLUSTAT, |
||||
| 644 | 26811555 |
EU |
78 | 1 |
Seizure, Hypomagnesaemia, Hypocalcaemia, Hypoparathyroidism, |
||||
PANTOPRAZOLE, |
||||
| 645 | 26811723 |
EU |
59 | 2 |
Megacolon, Seizure, Toxicity to various agents, Abdominal distension, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, |
||||
| 646 | 26811927 |
US |
44 | |
Seizure, Impaired gastric emptying, Oral candidiasis, Illness, Feeding disorder, Weight decreased, Abdominal discomfort, |
||||
UBLITUXIMAB, UBLITUXIMAB, |
||||
| 647 | 26811981 |
US |
2 | |
Amnesia, Seizure, |
||||
TOCILIZUMAB, |
||||
| 648 | 26812039 |
30 | ||
Seizure, Idiopathic generalised epilepsy, |
||||
LACOSAMIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 649 | 26812399 |
EU |
7 | 1 |
Mental impairment, Seizure, Autism spectrum disorder, Microcephaly, Aggression, Sleep disorder, Product use issue, |
||||
ALPRAZOLAM, LEVETIRACETAM, RISPERIDONE, |
||||
| 650 | 26816177 |
40 | 2 | |
Seizure, |
||||
OFATUMUMAB, |
||||
| 651 | 26816342 |
69 | ||
Injection site erythema, Injection site rash, Headache, Application site warmth, Seizure, |
||||
ONABOTULINUMTOXINA, CAPSAICIN, |
||||
| 652 | 26816348 |
67 | 1 | |
Seizure, |
||||
TRAMETINIB, DABRAFENIB, |
||||
| 653 | 26803779 |
19 | 1 | |
High-grade B-cell lymphoma, Seizure, Gastrointestinal haemorrhage, Post transplant lymphoproliferative disorder, Septic shock, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 654 | 26804125 |
US |
27 | 2 |
Asthma, Dyspnoea, Seizure, Rash, |
||||
DUPILUMAB, |
||||
| 655 | 26804649 |
MX |
2 | |
Acute kidney injury, Seizure, Off label use, |
||||
OBINUTUZUMAB, RITUXIMAB, BELIMUMAB, PREDNISONE, HYDROXYCHLOROQUINE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, CHLORPHENIRAMINE MALEATE, BUMETANIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, |
||||
| 656 | 26804885 |
KR |
2 | |
Seizure, |
||||
ESLICARBAZEPINE ACETATE, ESLICARBAZEPINE ACETATE, |
||||
| 657 | 26805247 |
US |
||
Seizure, |
||||
UPADACITINIB, |
||||
| 658 | 26805254 |
CO |
41 | 1 |
Seizure, Hyperglycaemia, Hypertension, |
||||
ECULIZUMAB, |
||||
| 659 | 26805324 |
31 | ||
Accidental exposure to product by child, Accidental overdose, Myoclonus, Seizure, Electrocardiogram QT prolonged, Mental status changes, Clonic convulsion, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 660 | 26805487 |
GB |
||
Pneumonitis aspiration, Encephalopathy, Hepatic steatosis, Intentional overdose, Hepatic function abnormal, Swollen tongue, Eosinophilia, Thrombocytosis, Toxicity to various agents, Paradoxical drug reaction, Toxicity to various agents, Hepatotoxicity, Altered state of consciousness, Depressed level of consciousness, Generalised tonic-clonic seizure, Seizure, Seizure, Agitation, |
||||
LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, CENOBAMATE, CENOBAMATE, CENOBAMATE, CLOBAZAM, CLOBAZAM, CLOBAZAM, CLOBAZAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 661 | 26805643 |
KR |
23 | 2 |
Seizure, Hyperventilation, |
||||
RAVULIZUMAB, RAVULIZUMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, TACROLIMUS, TACROLIMUS, METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, |
||||
| 662 | 26806215 |
JP |
80 | 1 |
Seizure, |
||||
APREMILAST, |
||||
| 663 | 26806250 |
US |
19 | |
Seizure, Product dose omission issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CLONAZEPAM, FLUTICASONE PROPIONATE, LEVETIRACETAM, POLYETHYLENE GLYCOL 3350, TIZANIDINE, |
||||
| 664 | 26806448 |
US |
63 | 1 |
Muscular weakness, Seizure, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 665 | 26806603 |
US |
51 | 1 |
Seizure, Hypertension, Glomerular filtration rate decreased, Dysstasia, Platelet count decreased, Pain, Abdominal pain upper, Product use in unapproved indication, |
||||
RILZABRUTINIB, RILZABRUTINIB, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, SENNOSIDES 8.6 MG TABLETS, SENNOSIDES, SENNA LEAF, SENNA, HYDROMORPHONE HYDROCHLORIDE, AVATROMBOPAG MALEATE, FENTANYL, POLYETHYLENE GLYCOL 3350, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREDNISONE, SCOPOLAMINE, BELZUTIFAN, |
||||
| 666 | 26806695 |
MX |
2 | |
Seizure, Cerebral cyst, |
||||
BARICITINIB, |
||||
| 667 | 26807065 |
IN |
19 | 1 |
Post transplant lymphoproliferative disorder, High-grade B-cell lymphoma, Gastrointestinal haemorrhage, Seizure, Septic shock, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 668 | 26807188 |
EU |
21 | |
Seizure, Hyponatraemic seizure, Hyponatraemia, Off label use, Underdose, Drug interaction, |
||||
CENOBAMATE, CENOBAMATE, OXCARBAZEPINE, |
||||
| 669 | 26807313 |
GB |
19 | 1 |
Suicidal ideation, Seizure, Rash, Swollen tongue, Mouth ulceration, Lymphadenopathy, Furuncle, White blood cell count increased, Swelling face, Acne, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, CARBAMAZEPINE, |
||||
| 670 | 26807382 |
US |
64 | 1 |
Seizure, Palmar-plantar erythrodysaesthesia syndrome, Cardiac failure congestive, Hypocalcaemia, Troponin increased, Retroperitoneal abscess, Gastric mucosal lesion, Decreased appetite, Impaired healing, Hypertension, Respiratory disorder, |
||||
LENVATINIB, DRONEDARONE, PEMBROLIZUMAB, CALCIUM CARBONATE, SUCRALFATE, FENOFIBRATE, FERROUS SULFATE, DEXTROSE MONOHYDRATE, DEXTROSE, INSULIN GLARGINE, LEVETIRACETAM, CHOLESTYRAMINE, BUMETANIDE, METOPROLOL SUCCINATE, LINAGLIPTIN, PANTOPRAZOLE, RIVAROXABAN, MELATONIN, MAGNESIUM OXIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 671 | 26807636 |
GB |
||
Seizure, Malaise, Rash erythematous, Skin fissures, Pain of skin, Peripheral swelling, Drug ineffective, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 672 | 26807642 |
US |
2 | |
Seizure, |
||||
BUPROPION, DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, |
||||
| 673 | 26807670 |
AU |
1 | |
Antipsychotic drug level increased, Seizure, |
||||
CLOZAPINE, CLOZAPINE, |
||||
| 674 | 26807828 |
CA |
21 | 2 |
Seizure, |
||||
ATOGEPANT, |
||||
| 675 | 26808147 |
US |
2 | |
Seizure, |
||||
DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, |
||||
| 676 | 26808258 |
US |
39 | 1 |
Intentional overdose, Seizure, Status epilepticus, Hypertension, Sinus tachycardia, Confusional state, Metabolic acidosis, Lactic acidosis, Shock, Bradycardia, Ventricular tachycardia, Bundle branch block left, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 677 | 26808570 |
65 | 2 | |
Cerebral haemorrhage, Fall, Haemorrhage, Muscle twitching, Seizure, Wound, |
||||
CLOZAPINE, DIVALPROEX SODIUM, LACTULOSE, LOXAPINE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SENNOSIDES 8.6 MG TABLETS, SENNOSIDES, SENNA LEAF, SENNA, |
||||
| 678 | 26808860 |
EU |
51 | 1 |
Drug interaction, Seizure, |
||||
VALPROIC ACID, ERTAPENEM, ERTAPENEM SODIUM, FLUCONAZOLE, ENOXAPARIN SODIUM, BACLOFEN, GABAPENTIN, |
||||
| 679 | 26808893 |
US |
||
Seizure, Product use complaint, Product size issue, |
||||
TROFINETIDE, |
||||
| 680 | 26810913 |
49 | 2 | |
Treatment delayed, Product dose omission in error, Seizure, Lymphadenopathy, Lymph node pain, Aphasia, Confusional state, Arthropathy, Asthenia, Dysstasia, Ligament sprain, Weight increased, Depression, Suicidal ideation, Anger, Aggression, Skin burning sensation, Dysarthria, Flushing, Product packaging difficult to open, |
||||
BRIVARACETAM, BRIVARACETAM, RIVAROXABAN, SPIRONOLACTONE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, FAMOTIDINE, FAMOTIDINE, |
||||
| 681 | 26798445 |
GB |
71 | |
Cerebrovascular accident, Blood pressure increased, Seizure, Headache, Chest pain, |
||||
INFLIXIMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, TENECTEPLASE, AMLODIPINE, LABETALOL, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LORAZEPAM, TRANEXAMIC ACID, MESALAMINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 682 | 26798575 |
US |
31 | |
Mental status changes, Condition aggravated, Seizure, Myoclonus, Electrocardiogram QT prolonged, Accidental overdose, Muscle rigidity, Generalised tonic-clonic seizure, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, |
||||
| 683 | 26798783 |
US |
34 | 1 |
Decreased appetite, Abnormal behaviour, Seizure, Restlessness, Obsessive-compulsive disorder, Serotonin syndrome, Insomnia, Intentional dose omission, Weight decreased, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 684 | 26798939 |
EU |
7 | |
Death, Muscular weakness, Pneumonia, Seizure, Off label use, |
||||
BACLOFEN, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, GABAPENTIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, RANITIDINE, ONABOTULINUMTOXINA, CLORAZEPATE DIPOTASSIUM, GENTAMICIN SULFATE, CLONIDINE, LACTULOSE, LEVALBUTEROL HYDROCHLORIDE, BUDESONIDE, VALPROIC ACID, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 685 | 26799128 |
17 | ||
Seizure, |
||||
| 686 | 26799146 |
GB |
19 | 1 |
Rash, Swelling face, Furuncle, Seizure, Suicidal ideation, Acne, Mouth ulceration, Swollen tongue, Lymphadenopathy, White blood cell count increased, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, CARBAMAZEPINE, |
||||
| 687 | 26799307 |
US |
31 | |
Clonic convulsion, Mental status changes, Myoclonus, Seizure, Electrocardiogram QT prolonged, Accidental overdose, Accidental exposure to product by child, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 688 | 26799341 |
GB |
2 | |
Seizure, |
||||
| 689 | 26799459 |
GB |
73 | |
Seizure, Lower respiratory tract infection, Cerebrovascular accident, Condition aggravated, Intentional dose omission, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 690 | 26799746 |
GB |
2 | |
Seizure, |
||||
| 691 | 26799889 |
66 | 1 | |
Seizure, |
||||
USTEKINUMAB, |
||||
| 692 | 26799898 |
EU |
74 | 1 |
Seizure, |
||||
NINTEDANIB, |
||||
| 693 | 26800141 |
US |
24 | 2 |
Seizure, |
||||
CANNABIDIOL, CANNABIDIOL, CANNABIDIOL, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, LACOSAMIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, TERBINAFINE HYDROCHLORIDE, TERBINAFINE, TERBINAFINE HYDROCHLORIDE TABLET, PLECANATIDE, CENOBAMATE, |
||||
| 694 | 26800344 |
US |
70 | 2 |
Hospitalisation, Seizure, Fall, |
||||
CANNABIDIOL, CANNABIDIOL, |
||||
| 695 | 26800357 |
GB |
90 | 1 |
Seizure, Dyspnoea, |
||||
BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, GLYCOPYRROLATE AND FORMOTEROL FUMARATE, |
||||
| 696 | 26800529 |
EU |
76 | 2 |
Seizure, |
||||
PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, FOLIC ACID, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, RIVASTIGMINE, |
||||
| 697 | 26800673 |
US |
6 | 1 |
Seizure, Off label use, Aggression, |
||||
STIRIPENTOL, ATOMOXETINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), CANNABIDIOL, FENFLURAMINE, GUANFACINE, GUANFACINE HYDROCHLORIDE, GAUNFACINE, |
||||
| 698 | 26800797 |
US |
2 | |
Seizure, Dysarthria, Pain in extremity, Arthralgia, Osteoarthritis, Vision blurred, Foreign body sensation in eyes, Eye irritation, Ocular hyperaemia, Eyelid oedema, Periorbital fat herniation, Conjunctival pigmentation, Fascial rupture, |
||||
ASFOTASE ALFA, |
||||
| 699 | 26800957 |
30 | ||
Seizure, Off label use, Drug ineffective, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LACOSAMIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, VALPROIC ACID, GABAPENTIN, PROPOFOL, HUMAN IMMUNOGLOBULIN G, RITUXIMAB, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 700 | 26801100 |
US |
14 | |
Seizure, Product use in unapproved indication, |
||||
CANNABIDIOL, CANNABIDIOL, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30